New product: Suboxone (buprenorphine/ naloxone) sublingual film (various strengths)

This product is licensed for use as a substitution treatment for opioid drug dependence in individuals aged >15 years who have agreed to be treated, within a framework of medical, social and psychological treatment. The intention of the naloxone component is to deter IV misuse.

electronic Medicines compendium